Related Experiment Videos

[Combination between fosfomycin and oxacillin or cefotaxime against methicillin-resistant Staphylococci and

Pathologie-Biologie
|June 1, 1983
PubMed

Insights

Fosfomycin (FOS) enhances beta-lactam antibiotics like oxacillin (OXA) and cefotaxime (CTX) against Gram-positive cocci. This synergistic effect shows potential for treating meningitis caused by resistant Staphylococci.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Gram-positive cocci resistance to oxacillin and cephalosporins is not linked to beta-lactamase synthesis.
  • Fosfomycin (FOS) may enhance beta-lactam action by inhibiting other stages of peptidoglycan synthesis.

Purpose of the Study:

  • To investigate the synergistic effects of combining fosfomycin with oxacillin or cefotaxime against Gram-positive cocci.
  • To evaluate the potential of these combinations for treating meningitis caused by methicillin-resistant Staphylococci.

Main Methods:

  • Tested fosfomycin-sensitive strains of S. aureus, S. epidermidis, and Enterococci.
  • Combined fosfomycin with oxacillin (OXA) or cefotaxime (CTX).
  • Determined Fractional Inhibitory Concentration (FIC) indices for synergistic effects.

Main Results:

  • Significant synergistic effects observed for FOS-OXA and FOS-CTX combinations.
  • FIC indices indicated synergy across S. aureus, S. epidermidis, and Enterococci strains.
  • Specific FIC ranges: FOS-OXA (0.17-0.39, 0.43) and FOS-CTX (0.29-0.47, 0.29).

Conclusions:

  • The combination of fosfomycin with oxacillin or cefotaxime demonstrates significant synergy against Gram-positive cocci.
  • Considering CSF concentrations, these combinations hold promise for treating meningitis caused by methicillin-resistant Staphylococci.

Related Concept Videos